Stay updated with breaking news from Research Inserm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Evotec SE / Key word: Miscellaneous Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity...
Lixudebart (ALE.F02) is a first-in-class monoclonal antibody in clinical development for multi-organ fibrosis Alentis Therapeutics ("Alentis"), the clinical-stage biotechnology company developing
A team from the Barcelona Institute for Global Health and the French National Institute of Health and Medical Research (Inserm), has carried out an analysis of hospital admissions related to high summer temperatures in Spain over more than a decade. The study concludes that the causes of hospitalization in which the heat has the most notable impact are:
BASEL, Switzerland, April 29, 2024--Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective immediately. Alberto joined Alentis in 2021 as Head of Oncology.
Latest news on GMO food, GMO crops, GMO labelling and genetically modified organisms